Related Experiment Video
Updated: Mar 11, 2026

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis
Vajihe Akbari1, Fatemeh Hendijani2
1V. Akbari is with the Department of Pharmaceutical Biotechnology and Isfahan Pharmaceutical Research Center, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran. F. Hendijani is with the Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Context:
The rising prevalence of type 2 diabetes requires increased efforts to find effective therapeutic agents for this complex condition. Following the recent observation that the gut microbiota is altered in diabetic patients, researchers investigated the effect of probiotics in patients with diabetes.
Objective:
The aim of this systematic review was to assess the effects of probiotic consumption on glycemic control in diabetic patients.
Data Sources:
PubMed, Scopus, Web of Science (formerly ISI Web of Knowledge), Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, and ProQuest Dissertations and Theses databases were searched up to November 2015.
Study Selection:
Clinical trials in diabetic patients in whom probiotics were administered as an intervention were included.
Data Extraction:
Primary outcomes were fasting blood glucose, insulin concentration, insulin resistance, and hemoglobin A1c. Secondary outcomes were adverse events.
Data Synthesis:
Of the 2736 reports that were screened, 13 clinical trials met the inclusion criteria. Pooling data from eligible clinical trials revealed that probiotic supplementation significantly (P < 0.05) decreased fasting blood glucose and hemoglobin A1c in diabetic patients, although the participants' characteristics (eg, body mass index) and the number and type of probiotic microorganisms affected the clinical response.
Conclusions:
Administration of probiotics appears to have a beneficial role in the management of type 2 diabetes; however, more clinical studies with adequate sample sizes and sound methodology are required to inform the development of evidence-based treatment guidelines.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...

